• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [24114 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2003     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Prospective study into the influence of high-dose chemotherapy with adjuvant treatment with peripheral stem cells on the disease-free survival of patients with mammary carcinoma and four or more metastatic lymph glands in the armpit - primary research
2005     Institute for Clinical Effectiveness and Health Policy (IECS) Prostacyclins (epoprostenol, iloprost, treprostinil and beraprost) for the management of primary pulmonary hypertension and pulmonary hypertension in collagen vascular disease
2009     Institute for Clinical Effectiveness and Health Policy (IECS) Prostacyclins (epoprostenol, iloprost, treprostinil and beraprost) for the management of primary pulmonary hypertension and pulmonary hypertension in collagen vascular disease
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Prostaglandin analogues for ophthalmic use: analysis of clinical and cost-effectiveness
2001     HAYES, Inc. Prostascint
2017     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Prostate artery embolisation for benign prostatic hyperplasia
2017     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Prostate artery embolisation for benign prostatic hyperplasia
2018     National Institute for Health and Care Excellence (NICE) Prostate artery embolisation for lower urinary tract symptoms caused by benign prostatic hyperplasia. NICE interventional procedures guidance 611
2018     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Prostate artery embolisation: poor design and reporting impact the value of current systematic reviews
2016     Institute for Clinical Effectiveness and Health Policy (IECS) Prostate bipolar transurethral resection for the treatment of benign prostatic hyperplasia
2006     NIHR Horizon Scanning Centre (NIHR HSC) Prostate cancer gene 3 (Progensa PCA3) assay in the diagnosis of prostate cancer: horizon scanning technology briefing
2017     Health Quality Ontario (HQO) Prostate cancer patient perspectives on the use of information in treatment decision-making: a systematic review and qualitative meta-synthesis
2011     Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Prostate cancer screening
1996     Australian Health Technology Advisory Committee (AHTAC) Prostate cancer screening (consumer statement)
1996     Australian Health Technology Advisory Committee (AHTAC) Prostate cancer screening (executive summary)
1996     Australian Health Technology Advisory Committee (AHTAC) Prostate cancer screening (technical report)
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Prostate cancer screening: a review of the guidelines
1999     Basque Office for Health Technology Assessment (OSTEBA) Prostate cancer screening: evidence synthesis and update (INAHTA Joint Project)
2004     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Prostate Oncoguide
2010     HAYES, Inc. Prostate Px (Aureon Laboratories Inc.) for prediction of recurrence of prostate cancer
2006     HAYES, Inc. Prostate saturation biopsy for diagnosis of prostate cancer
2005     Medical Services Advisory Committee (MSAC) Prostate specific antigen (PSA) near patient testing for diagnosis and management of prostate cancer
1995     Health Services Utilization and Research Commission (HSURC) Prostate specific antigen (PSA) testing
2003     NIHR Health Technology Assessment programme Prostate Testing for Cancer and Treatment (ProtecT) feasibility study
1999     NIHR Health Technology Assessment programme Prostate trials office (PROTO): co-ordinating trials of new technologies in the treatment of BPH
2009     NIHR Health Technology Assessment programme Prostate trials office (PROTO): co-ordinating trials of new technologies in the treatment of BPH
2002     Institute for Clinical Evaluative Sciences (ICES) Prostate-specific antigen (PSA) screening in asymptomatic men
2015     Health Quality Ontario (HQO) Prostate-Specific Antigen (PSA)–based population screening for prostate cancer: an economic analysis
2015     Health Quality Ontario (HQO) Prostate-Specific Antigen (PSA)–based population screening for prostate cancer: an evidence-based analysis
2002     HAYES, Inc. Prostate-specific antigen testing for prognosis and monitoring of patients with prostate cancer
2003     HAYES, Inc. Prostate-specific antigen testing for screening and early detection of prostate cancer
2006     Belgian Health Care Knowledge Centre (KCE) Prostate-specific-antigen (PSA) for the screening of prostate cancer
2021     Ontario Health Prostatic artery embolization for benign prostatic hyperplasia
1992     Danish Institute for Health Services Research (DSI) Prostatic cancer in the Nordic Countries
2022     National Institute for Health and Care Excellence (NICE) Prostatic urethral temporary implant insertion for lower urinary tract symptoms caused by benign prostatic hyperplasia. NICE interventional procedures guidance 737
2008     Agenzia nazionale per i servizi sanitari regionali (Agenas) Prostheses for primary total hip replacement in Italy
2009     Agenzia nazionale per i servizi sanitari regionali (Agenas) Prostheses for primary total knee replacement in Italy
2012     The Regional Health Technology Assessment Centre (HTA-centrum) Prosthetic arthroplasty in primary shoulder osteoarthritis
1994     University HealthSystem Consortium (UHC) Prosthetic hip and knee arthroplasty
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Prosthetic intervertebral disc replacement
2010     National Institute for Health and Care Excellence (NICE) Prosthetic intervertebral disc replacement in the cervical spine. NICE interventional procedures guidance 341
2009     National Institute for Health and Care Excellence (NICE) Prosthetic intervertebral disc replacement in the lumbar spine. NICE interventional procedures guidance 306
2010     The Swedish Council on Health Technology Assessment (SBU) Prosthetic rehabilitation of partially dentate or edentulous patients
2013     NIHR Horizon Scanning Centre (NIHR HSC) PROSTVAC Immunotherapy for chemotherapy-naïve hormone-relapsed prostate cancer
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Protease inhibitor use for chronic hepatitis C infection in prior null responders and recurrent hepatitis C infection post liver transplant: a review of the clinical evidence
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Protease inhibitor use for chronic hepatitis C infection in special populations: a review of the clinical evidence and guidelines
1996     Health Council of the Netherlands Gezondheidsraad (GR) Protection against diphtheria
1996     Health Council of the Netherlands Gezondheidsraad (GR) Protection against Hepatitis B
2015     Canadian Agency for Drugs and Technologies in Health (CADTH) Protein testing in patients with multiple myeloma: a review of clinical effectiveness and guidelines
2008     HAYES, Inc. Prothrombin G20210A for risk assessment for venous thromboembolism (VTE) or obstetric complications
2025     Health Information and Quality Authority (HIQA) Protocol for a health technology assessment of immunisation against respiratory syncytial virus in Ireland
2024     Health Information and Quality Authority (HIQA) Protocol for a health technology assessment of screening for abdominal aortic aneurysm in men
2025     Health Information and Quality Authority (HIQA) Protocol for a health technology assessment of teledermatology to support the management of primary care referrals
2025     NIHR Health Technology Assessment programme Protocol for DexEnceph: a randomised controlled trial of dexamethasone therapy in adults with herpes simplex virus encephalitis
2008     Quality Improvement Scotland (NHS QIS ) Protocol for systematic review on provision of patient information
2025     Health Information and Quality Authority (HIQA) Protocol: development of a tool for the collection of costs attributable to infectious disease outbreaks in public acute hospitals
2015     NIHR Health Technology Assessment programme Protocolised Management In Sepsis (ProMISe): a multicentre randomised controlled trial of the clinical effectiveness and cost-effectiveness of early, goal-directed, protocolised resuscitation for emerging septic shock
2019     NIHR Health Technology Assessment programme Protocolised non-invasive compared with invasive weaning from mechanical ventilation for adults in intensive care: the Breathe RCT
2017     Penn Medicine Center for Evidence-based Practice (CEP) Protocols for discontinuing the use of 1:1 patient sitters in the acute care setting
2005     Institute of Health Economics (IHE) Protocols for stillbirth investigation
2005     Alberta Heritage Foundation for Medical Research (AHFMR) Protocols for stillbirth investigation
2020     Austrian Institute for Health Technology Assessment (AIHTA) Proton and carbon ion therapy - an update on indications
1998     ECRI Proton beam radiation therapy for prostate cancer
2004     HAYES, Inc. Proton beam therapy
2014     Institute for Clinical and Economic Review (ICER) Proton beam therapy
2010     VA Technology Assessment Program (VATAP) Proton beam therapy for cancer
2021     Ontario Health Proton Beam Therapy for Cancer in Children and Adults: A Health Technology Assessment
2017     HAYES, Inc. Proton beam therapy for non-small cell lung cancer
2010     Blue Cross Blue Shield Association (BCBS) Proton beam therapy for non-small-cell lung cancer
2004     HAYES, Inc. Proton beam therapy for ocular tumors, hemangiomas, and macular degeneration
2006     HAYES, Inc. Proton beam therapy for prostate cancer
2010     Blue Cross Blue Shield Association (BCBS) Proton beam therapy for prostate cancer
2004     HAYES, Inc. Proton beam therapy for prostate cancer
2016     HAYES, Inc. Proton beam therapy for prostate cancer
2006     Adelaide Health Technology Assessment (AHTA) Proton Beam Therapy for the treatment of cancer
2021     Malaysian Health Technology Assessment (MaHTAS) Proton beam therapy for the treatment of cancer - an update
2017     Canadian Agency for Drugs and Technologies in Health (CADTH) Proton beam therapy for the treatment of cancer in children and adults: a health technology assessment
2007     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Proton beam therapy for the treatment of neoplasms involving (or adjacent to) cranial structures
2007     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Proton beam therapy for the treatment of uveal melanoma
2006     HAYES, Inc. Proton beam therapy for thoracic and abdominal organs
2019     Belgian Health Care Knowledge Centre (KCE) Proton beam therapy in adults
2008     HAYES, Inc. Proton magnetic resonance spectroscopy for diagnosis of brain tumors
2001     University HealthSystem Consortium (UHC) Proton pump inhibitors update
2002     Centre for Clinical Effectiveness (CCE) Proton pump inhibitors versus H2 antagonists or placebo in treating bleeding peptic ulcer
2009     Health Council of the Netherlands Gezondheidsraad (GR) Proton radiotherapy
2002     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Protontherapy (2 vols)
2013     NIHR Horizon Scanning Centre (NIHR HSC) ProUroScan™ for imaging abnormalities of the prostate
2011     HAYES, Inc. Provenge (Dendreon Corp.) vaccine for treatment of prostate cancer
2012     HAYES, Inc. Provent sleep apnea therapy (Ventus Medical Inc.)
2013     HAYES, Inc. Provent sleep apnea therapy (Ventus Medical Inc.) for obstructive sleep apnea
2011     HAYES, Inc. Provent sleep apnea therapy (Ventus Medical Inc.) for obstructive sleep apnea
2007     Center for Medical Technology Assessment (CMT) Provider payment systems in the health care sector
2005     Health Council of the Netherlands Gezondheidsraad (GR) Providing information on significant developments in health care; identification of new and changing health technology
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Providing rehabilitation services for seven days versus five days per week: clinical effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Providing rehabilitation services for seven days versus five days per week: clinical effectiveness and guidelines
2017     NIHR Health Technology Assessment programme Provision of information about newborn screening antenatally: a sequential exploratory mixed-methods project
2017     NIHR Health Technology Assessment programme Provision of information about newborn screening antenatally: a sequential exploratory mixed-methods project
2009     Quality Improvement Scotland (NHS QIS ) Provision of information to patients with long term conditions
2001     Medical Services Advisory Committee (MSAC) Provision of pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension
2004     NIHR Health Technology Assessment programme Provision, uptake and cost of cardiac rehabilitation programmes: improving services to under-represented groups